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Catharanthus roseus (L.) known as Madagascar periwinkle (MP) is a legendary medicinal plant mostly because of possessing two
invaluable antitumor terpenoid indole alkaloids (TIAs), vincristine and vinblastine. The plant has also high aesthetic value as an
evergreen ornamental that yields prolific blooms of splendid colors. The plant possesses yet another unique characteristic as an
amiable experimental host for the maintenance of the smallest bacteria found on earth, the phytoplasmas and spiroplasmas, and
serves as a model for their study. Botanical information with respect to synonyms, vernacular names, cultivars, floral morphology,
and reproduction adds to understanding of the plant while the geography and ecology of periwinkle illustrate the organism’s
ubiquity. Good agronomic practices ensure generous propagation of healthy plants that serve as a source of bioactive compounds
and multitudinous horticultural applications. The correlation between genetic diversity, variants, and TIA production exists. MP
is afflicted with a whole range of diseases that have to be properly managed. The ethnobotanical significance of MP is exemplified
by its international usage as a traditional remedy for abundant ailments and not only for cancer. TIAs are present only in micro
quantities in the plant and are highly poisonous per se rendering a challenge for researchers to increase yield and reduce toxicity.
1. Introduction
The genus Catharanthus consists of eight species of which
seven are endemic to Madagascar and one, C. pusillus, is
endemic to India. Catharanthus roseus, Madagascar periwin-
kle (hereafter MP), is an important floral species in horti-
culture and is one of the few pharmacological plants that
have a long history. It could be traced to Mesopotamian
folklore going as far back as 2600 BCE. This plant still plays
a considerable role today in herbal and traditional medicine
for treatment of various diseases. The therapeutic properties
were ascribed to a number of chemicals in the alkaloid class
sometime in the mid-1950s [1, 2].
Medicinal plants have played a key role in world health
care [3]. MP apart from being the most important source of
natural drugs is also one of the premier model organisms to
study plant alkaloidmetabolites due to its ability to synthesize
awide range of terpenoid indole alkaloids (TIAs)with a broad
pharmaceutical spectrum [4–7]. However, MP is potentially
poisonous as are many plants of the dogbane family. Nowa-
daysMP comes inmany different varieties and colors ranging
from white, hot pink, and mauve to the original pink as
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a result of breeding experiments. As previously published
reviews onMPmostly concentrate on the pharmaceutical and
chemical compounds of the herb, lack of information about
the other features of the species is extremely tangible.The aim
of this review is to provide insights into agrotechnological,
biological, ecological, and medicinal aspects (particularly
anticancer compounds) ofMP aswell as updated information
on the new cultivars that have been introduced to the
horticultural industry.
2. Botany
2.1. Taxonomic Classification. Inconsistency of nomenclature
in the literature is due to changes made in plant taxonomic
classification with continuous research [8]. In the appellation
of Catharanthus roseus (L.) G. Don, Catharanthus means
clean or pure flower in Greek, roseus signifies being rose-
colored in Latin, L. is the standard abbreviation for Linnaeus,
who first published the plant’s description, and G. Don refers
to George Don, who named the flower as such in 1837 [6].
Catharanthus roseus known as the Madagascar periwin-
kle (MP) was formerly classified as the species Vinca rosea
L. (1759) (basionym or original name), Pervinca rosea (L.)
Moench (1794), Lochnera rosea (L.) Rchb. ex Endl. (1838), and
Ammocallis rosea (L.) Small (1903), which are homotypic syn-
onyms [9]. Vinca guilelmi-waldemarii Klotzsch is recognized
as a heterotypic synonym [10].
Below describes the classification of the Catharanthus
roseus species.
Domain: Eukarya: eukaryotes.
Kingdom: Plantae: plants.
Subkingdom: Tracheobionta: vascular plants.
Superdivision: Spermatophyta: seed plants.
Division: Magnoliophyta: flowering plants.
Class: Magnoliopsida: dicotyledons.
Subclass: Asteridae.
Superorder: Gentiananae.
Order: Gentianales.
Family: Apocynaceae: dogbane.
Subfamily: Rauvolfioideae.
Tribe: Vinceae.
Genus: Catharanthus G. Don.
Specific epithet: roseus (Linnaeus) G. Don.
Botanical name: Catharanthus roseus (Linnaeus) G.
Don (1837): Madagascar periwinkle [8, 11–13].
Vernacular names of the herb in various cultures and
languages have been listed in Table 1.
2.2. Morphological Characteristics. MP is a perennial or
annual evergreen, semishrub or herbaceous plant that grows
up to one meter in height and secretes milky latex. The roots
extend to 70 cm in depth.The leaves of the plant are elliptical
Table 1: Vernacular names ofMadagascar periwinkle (Catharanthus
roseus) in different languages∗.
Language Common name
Bengali Nayantara
Chinese Chang Chun Hua
Dutch Roze maagdenpalm
English
Bright-eyes, Cape periwinkle, graveyard plant,
Madagascar periwinkle, old-maid,
old-maid-flower, rose periwinkle, rosy periwinkle
Ethiopia Phlox
Creole Bigalo
French Pervenche de Madagascar, rose ame`re, sorcerer’sviolet
German Zimmerimmergru¨n
Creole Kaka poule
Hindi Sadabahar, Baramassi, Ainskati, Ushamanjairi
Indonesian Tapak dara, kembang sari cina
Konkani Sadapushpa
Malayalam Nithyakalyani, Savakkottappacha, Ushamalari
Malay Kemunting cina
Marathi Sada-phul (Sadaphuli)
Myanmarese Thin-Baw-MA-Hnyo
Persian Gul-e-farang
Portuguese
Boa-noite, Boa-tarde, Lavadeira, Pervinca-rosa,
Vinca-de-gato,
Vinca-de-madagascar, Vina-ro´sea
Punjabi Rattanjot
Sanskrit Nityakalyani
Krio Ngyange
Afrikaans Kanniedood
Spanish Chatas, Chula, Pervinca de Madagascar, Vincapervinca, Hierba doncella
Swedish Rosensko¨na
Tamil Sudukattu mallikai
Telugu Billaganneru
∗References: [9, 17].
to oblong in shape, 2.5–9 cm long, 1–3.5 cm broad, glossy
green above, and pale green below with a pale midrib and
opposite in orientation. Petioles are green or red and 1–1.8 cm
long. The inflorescence is racemose. Flowers are pentamer-
ous, actinomorphic, and colored pink, rose-purple, blue,
salmon, scarlet, or white with purple, red, pink, pale yellow,
or white “eye” in the center and a mauve throat (Figures
1(a)–1(c)). The corolla tube is cylindrical, 2-3 cm long with
five petal-like lobes. Stamens are inserted 0.4–0.6 cm below
the corolla mouth, consisting of very short white colored
filaments and filiform, subsessile anthers. Pistils range from
17 to 26mm in length, made up of two narrow, long carpels
consisting of a glabrous stigma, style, ovary, and 2-seriate
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Figure 1: (a) Artificial hybrids of MP in flower stage; (b) wild types with purple flowers “rosea”; (c) wild types with white flowers “alba”;
(d) fruits which are composed of two free narrow cylindrical follicles; (e) seeds inside the follicle; (f) seeds. All images represent the real sizes,
approximately.The artificial hybrids are clearly differentiated from those wild types due to their floral architecture and petals structure which
are wider, thicker, and more compressed than the wild ones.
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ovules. Each fruit is composed of two free, narrow cylindrical
follicles, 2–4.5 cm long and 3mm wide, which houses 10–
20 oblong, minute seeds, 2-3mm in length (Figures 1(d)–
1(f)). These seeds comprise black cotyledons which are flat
and slightly shorter than the radical and a scanty endosperm
[9, 14–16].
3. Geographical Distribution and Ecology
MP is a plant species native to Western Indian Ocean’s large
island ofMadagascar next to Africa. It has been introduced as
a popular ornamental plant in many tropical and subtropical
regions worldwide. This herb is widely cultivated commer-
cially in Spain, United States, China, Africa, Australia, India,
and Southern Europe for its medicinal uses. The drugs
derived from this plant findmajor markets in USA, Hungary,
West Germany, Italy, The Netherlands, and UK [17–19].
MP is a tolerant plant against abiotic stresses such as
drought and salinity, which can survive in a variety of habitats
such as sandy soils, shrublands, grasslands, inland river
banks, dunes in savannas, dry wastelands, houses, roadsides,
and even beaches and limestone rocks all due to its hardiness.
It can be found proliferating at a range of altitudes from 0 to
900meters.MPprefers a soil pHof 5.5–6.5, canwithstand salt
up to 2000 ppm, andhas excellent heat and drought tolerance.
It thrives well in dry, frost-free, and humid environments
with favorable moisture conditions, under full sun or partial
shade, and in soils that are well-drained. It bears flowers and
fruits the whole year in warm climates. MP cannot withstand
too much water, wet soils, or a cool spring. Under adverse
weather or in poorly drained soils, MP turns yellow-green
while overwatering could lead to bacterial and fungal rot
diseases of stem and root [9, 10, 20].
4. Genetics
4.1. Cytology. The chromosome number of all species of the
genus Catharanthus is 2𝑛 = 16 [9, 21, 22] with a genome
size of 1500Mbp (van Iren, unpublished). Doubling of chro-
mosome number, tetraploidy, has been induced by colchicine
treatment that resulted in an increase in TIAs, larger stomata,
branches, and leaves, although there was reduced pollen
fertility and poor seed set compared with diploid plants [23,
24].
4.2. Reproduction. MP is a unique species because of its
self-compatibility unlike most of the other species in the
family. However, intraflower self-pollination does not nor-
mally occur in periwinkle because of the physical sep-
aration between the stigma and anthers, a phenomenon
known as reverse herkogamy, when the stigma is recessed
below the level of anthers [25–28]. Even so, some periwin-
kles contain elongated ovaries or styles, thus allowing for
intraflower self-pollination. Basically, MP is an allogamous
(cross-pollinating) species. The degree of outcrossing varies
with environmental conditions and the presence of seasonal
pollinators, mainly butterflies and moths, whereby the floral
structure is adapted to pollination by these long-tongued
insects [29]. Self-incompatible strains of MP engage in natu-
ral interspecific hybridization which is found to be common
locally in Madagascar [18, 30]. But in all reality, both types of
pollination occur in MP.
4.3. Genetic Diversity. Although many aspects of alkaloid
biosynthesis have been investigated, the genetic variation
between accessions in relation to alkaloid content and the
effects of breeding for flower color or growth habit on the
levels of vinblastine (VBL) and vincristine (VCR) are still
poorly understood. Dissimilar cultivars accumulate TIAs in
various parts of the plant. Hence, efforts need to be made
to identify accessions out of the vast resources of naturally
occurring MP germplasm for their chemotherapeutic poten-
tial, determine the type of plant tissues accumulating these
active compounds, and administer genetic improvements for
higher yield of alkaloids [31, 32]. A summary of genetic
relatedness among C. roseus accessions based on different
markers is shown in Table 2.
5. Agrotechnology
5.1. Cultivation. Even though many investigations have been
carried out over the last few decades on the phytochemical
and therapeutic properties of MP, few studies have been
conducted on the agronomic and genetic aspects of this herb.
MP is very easy to cultivate. The seed germinates within a
week in the dark. Seeds are easily sown directly or seedlings
transplanted at a seeding rate of 2-3 kg/ha and 0.5 kg/ha,
respectively [33–35]. In a temperate climate, seeding takes
place from March to April, the best temperature for seed
germination being 25–30∘C. Seeds should be planted with a
spacing of 45× 30 cmor 45× 45 cm. Transplanting takes place
between June and July or September and October in the case
of 45–60-day-old seedlings spaced at 45 × 20 cm. Softwood
stem cuttings or apical semiripe cuttings could also easily be
grown in spring or summer under lighted conditions at 20∘C
and on drained compost [19, 36].
Effects of different levels of nitrogen application rates
from 50 to 150 kg/ha on plant yield have been tested
with 150 kg/ha giving the best response [37–41]. Root and
shoot dry weights were greatest when high nitrate-N to
ammonium-N ratio fertilizerswere employedwith high levels
of ammonium-N having an adverse effect [20].
A planting density of 75000 plants/h and nutrient dose
comprising a mixture of 15 t/ha farm yard manure (FYM)
plus 80 kg/ha N with irrigation (4-5 times) or 15 t/ha FYM +
40 kg/ha N under rainfed conditions are recommended
regimes in India. Dry yield (DY) was reported at 1.8 t/ha
for leaves and 0.8 t/ha for roots [42]. 3.06 t/ha DY could be
obtained with N, P (P
2
O
5
), and K (K
2
O) application at a rate
of 150 : 40 : 40 kg/ha [40]. Mineral nutrition can increase the
yield and the alkaloid content in periwinkle [43]. Nitrogen
fertilization has been found to increase leaf and root yields,
significantly. Alkaloids are nitrogenous compounds; there-
fore, nitrogen may play an important role in the biosynthesis
and accumulation of alkaloids in plants [40].
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Table 2: Genetic diversity in Catharanthus roseus accessions using different marker systems.
NUA1 Type of marker(s) Clusteringmethod
Similarity
indices Ranges
Genetic
variation
References
8 RAPD2 UPGMA7 NP 86–100 Low-moderate [159]
8 AFLP3 UPGMA NP 85–100 Low-moderate [159]
8 1H NMR∗ UPGMA NP 0–3 Moderate [159]
8 Chemical (ion content) UPGMA Euclideandistance 32–100 High
[160]
14 ISSR4 SAHN8 Jaccard 0.57–1.00 Moderate [161]
14 RAPD SAHN Jaccard 0.4–0.97 High [161]
32 Morphochemical/phytochemical UPGMA Nei’s 55–100 Moderate [131]
50 Phytochemical/enzymatic — Meancomparison — High/moderate
[162]
72 Isozyme/phytochemical NP9 Meancomparison NP Moderate
[30]
40 ISSR — Nei’s 0.15–0.9 High [163]
9 RAPD/ISSR/SSR5 UPGMA Jaccard 0.19–0.73/0.25–0.64/0.26–0.73 High [164]
32 SSR/STMS6 UPGMA Nei and Li’s 0.07–0.79 High [165]
1Number of used accessions, 2RAPD: random amplified polymorphic DNA, 3AFLP: amplified fragment length polymorphism, ∗1H NMR: hydrogen-1 nuclear
magnetic resonance, 4ISSR: intersimple sequence repeat, 5SSR: simple sequence repeat, 6STMS: sequence-tagged microsatellites sites, 7UPGMA: unweighted
pair group method with arithmetic mean, 8SAHN: sequential agglomerative hierarchical nonoverlapping, and 9NP: not presented in the related reference.
Planting distance 30 × 20 cm produced the highest foliage
and root yields [44]. Highest foliage yield was also reported at
45 × 20 cm distance with an NPK 20 : 30 : 30 kg/ha formula-
tion [45]. An early June planting, spacing at 30 × 50 cm, NPK
application of 150 : 40 : 30 kg/ha, and a late September harvest
are recommended for higher yields in Iran [41]. The best
sowing date under temperate climatic conditions in Poland
is the second half of May, an optimum planting distance is 60
× 60 cm, while harvesting in early September is ideal [19, 46].
5.2. Wild Types and Breeding Synthetic Cultivars. There are
two types of MP in the wild, one with pink flowers and
reddish stems and the other white flowers and green stems
often found growing sympatrically. MP has been bred since
the 1920s [47]. Over the past two decades, conventional
breeding techniques conducted by horticulturists and seed
companies entailed crossing C. roseus with other species
that resulted in a large number of marvelous new cultivars
or varieties. Breeding not only improved floral traits such
increasing color range, blooms, and size; enhancing plant
growth; augmenting tolerance to disease and cooler growing
conditions, but also boosted herbage and alkaloid yield. For
example, Dhawal white flower cultivar not only produces a
higher plant and alkaloid yield, but also is dieback-tolerant
[48]. Nirmal white flower cultivar can endure salt and fungal
infection by Pythium aphanidermatum and Phytophthora
nicotianae [15] and possesses a coveted leafless inflorescence
(lli) architecture that increased the flower frequency [49].
The different cultivars are usually arranged in series,
and subsequent grouping is based on corolla color [50].
Periwinkle plants now are readily available for gardeners
worldwide in pink, deep rose, red, scarlet, white, white with a
red eye, lavender blue, peach, apricot, orchid, burgundy, and
many other shades. An international register of Catharan-
thus cultivars was published in 1998. There are few reliable
compendia on this topic, and reliance has to be placed on
information from the web. Series and cultivars of MP [10, 47,
51–54] are presented in Tables 3 and 4, respectively. There
are also nonseries selections that include Apricot Delight,
Blue Pearl, Parasol,MorningMist,Merry-Go-Round, Fanfare
Orchid, Dwarf Little Salmon [55], Pink Panther [56], Santa Fe
[57], and Snow Flake.
There have been numerous studies performed on two
varieties, rosea and alba, of MP. All the results revealed that
rosea is superior to alba in the overall performance of the
plant. Rosea has higher alkaloid content in leaves and roots
and more antioxidant activity than alba; rosea fared much
better under water stress [58–60]. Triadimefon treatment
increased the antioxidant potential and alkaloid ajmalicine
content in rosea more than in alba [61].
5.3. Horticulture. MP is an easy growing and spreading
per ennial herb that has multitudinous horticultural uses:
decoration, annual ground cover, bedding, edging, border,
container gardening, mass planting, naturalizing, hanging
basket, and wall cascade. Surprisingly, the herb is naturalised
for medicinal purposes in many parts of the world while
it is considered as a weed or as an ornamental plant in
the other parts. This conflict is the result of the MP’s long
history as a horticultural variety, especially over the past
two centuries [62]. Horticultural practices caused changes
in the distribution and biology of MP and this, in turn,
generated changes in people’s valuation of the species [62].
The new lines are novel in displaying an increased number of
flowers on the inflorescence unhindered by leaves. In the new
floricultural lines the overflowering “LLI” trait was combined
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Table 3: Catharanthus roseus series.
Series Characteristics
Carpet Height: 3-4 inches (7.6–10.2 cm), width: 24 in (60 cm), dwarf, great for groundcovers, blooms all summer.
Cobra Height: 6–12 in (15–30 cm); spacing: 6–9 in (15–22 cm), flower size: 5-6 cm, compact, drought-tolerant, suitable
for xeriscaping and growing in container.
Cooler Height: 10–14 in (30–35 cm), spread: 15–20 cm, low growing compact plants, more tolerant of cool, wet
conditions, vibrant colors.
Cora
Height: 14–16 in (35–40 cm), width 22–25 in (55–62 cm), large bold bright flowers, first series to be resistant to
the “sudden death,” bloom early, heat tolerant, Disease-resistant to the fungus (Phytophthora) causing aerial
blight.
Heat Wave Height: 14–20 inches, remarkable tolerance to heat and drought, blooms early, suitable for containers or hanging
baskets.
First Kiss Height: 10–14 in (28 cm), compact, large-flowered (flower size: 6 cm) and very heavy blooming.
Jaio Compact, vigorous, heat and drought tolerant, disease-resistant.
Little Height: 10 to 14 in, best used in small patio planters and decorative pots.
Mediterranean Grows 5-6 inches tall, cascading habit, fairly vigorous, excellent heat and drought tolerance, performs well in
very warm conditions, many color combinations, good for use in hanging baskets or window boxes.
Nirvana Upright and cascading types, resistant to the fungus causing aerial blight.
Pacifica
Height: 14–20 in (35–50 cm), spread 15–20 cm, open-pollinated group, blooms early, 2-inch flowers with
overlapping petals, heat and humidity tolerant, more stress tolerant on the bench and in the garden, very
floriferous.
Pretty Height: 12 inches (30.5 cm), compact, multiflowered plants.
Solar Heat and humidity tolerant, ideal for early sowings, early flowering, perfect for packs and pots, better disease
tolerant.
Stardust Height: 25–30 cm, compact, many flowered, blooms have a star-shaped, solid white center and bright petal
border.
Sunstorm Large-flowered, compact and tolerant of both hot and cool growing conditions.
Titan
Height: up to 16 in (35–40 cm), spread 10–12 in (25–30 cm), bushy growing habit, vigorous, more
disease-resistant than other Vinca series, cool and drought tolerant, earlier flowering, has neat mounding
habits, large-flowered, flowers profusely, highest seed quality.
Tropicana Height 14–20 in, fast-growing, blooms early, large rounded flowers, heat and humidity tolerant.
Tutti Frutti Large-flowered, heat and drought tolerant.
Victory Height: 25–35 cm, spread 15–20 cm, intense, clear colors, compact growing habit, disease tolerance, low and
early basal branching, formed large round flowers with overlapping petals.
Viper Height: 20–50 cm, F1 Viper is the king of Vinca-vigorous, large mounded plant covered in massive flowers.
Vitesse Height: 32–35 cm, compact with basal branching, ideal for early planting.
with variation in plant height, petal and eye colors, and
tolerance to the common fungal diseases [60].
5.4. Model Plant in Phytopathology. MP acts as a unique
host for a series of microorganisms such as bacteria and
fungi. Hence, the herb serves as a model plant for studying
the biology of microbial pathogenesis. As an invaluable
model indicator plant for mollicutes in plant pathology,
MP has no peers. It is an excellent experimental host for
most phytoplasmas and spiroplasmas where high titres are
achieved [63]. MP is highly susceptible to phytoplasma
infection from different crops and exhibits highly distinctive
symptoms such as phyllody and virescence.This popular herb
is commonly used as a source plant to maintainmollicutes by
grafting, dodder, or vector transmission. Infecting mollicutes
induce symptoms on this experimental host similar to those
on the original hosts [64]. MP has also been used as a
model plant to study the interaction between the endophytes
Methylobacterium mesophilicum and Xylella fastidiosa [65].
6. Diseases and Management
6.1. Diseases. Periwinkle plants are known to be susceptible
to the aster yellows (16SrI) group phytoplasma in Argentina
[66], Egypt [67], India [68], Malaysia [69, 70], and Myanmar
[71] and have also been found to be naturally infected with
spirea stunt (16SrIII-E), peach yellow leaf roll (16SrIII-A),
clover proliferation (16SrVI), potato witches’ broom (16SrVI-
A) [72], Mexican periwinkle virescence (16SrXIII) [73], and
Malaysian periwinkle virescence (16SrXXXII) [74, 75]. MP
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Table 4: Available cultivars of Catharanthus roseus.
Series Cultivars
Carpet Rose Carpet, Pink Carpet, Magic Carpet.
Cobra Cobra Apricot, Cobra Orchid W/Eye, Cobra Passion Fruit, Cobra Peppermint, Cobra Purple, Cobra PurpleW/Eye, Cobra Red, Cobra Red W/Eye, Cobra Rose, Cobra Strawberry Red, Cobra White.
Cooler
Cooler Apricot; Cooler Blush; Cooler Coconut; Cooler Deep Orchid, Cooler Grape; Cooler Hot Rose, Cooler
Icy Pink; Cooler Lavender Halo, Cooler Mixture, Cooler Orchid; Cooler Orchid Deep, Cooler Peppermint;
Cooler Peppermint Improved; Cooler Pink; Cooler Raspberry Red; Cooler Red; Cooler Rose; Cooler
Strawberry.
Cora Cora Apricot, Cora Burgundy, Cora Deep Lavender, Cora Lavender, Cora Mix, Cora Pink, Cora Punch, CoraViolet, Cora White, Cora Cascade Cherry, Cora Cascade Lilac, Cora Cascade Polka Dot.
Heat Wave
Heatwave Apricot, Heatwave Blue W/Eye, Heatwave Burgundy, Heatwave Cherry, Heatwave Deep Rose,
Heatwave Formula Mixture, Heatwave Grape, Heatwave Midnight Mix, Heatwave Orchid, Heatwave Peach,
Heatwave Peppermint, Heatwave Pink, Heatwave Raspberry, Heatwave Red, Heatwave Rose, Heatwave Santa
Fe, Heatwave Southwest Mix, Heatwave White.
First Kiss
First Kiss Apricot, First Kiss Blueberry, First Kiss Blush, First Kiss Cherry red, First Kiss Coral, First Kiss Icy
Pink, First Kiss Orchid, First Kiss Peach, First Kiss Polka Dot, First Kiss Raspberry, First Kiss Rose, First Kiss
Ruby, First Kiss Sunrise, First Kiss Think Pink, First Kiss White.
Jaio Jaio Dark Red, Jaio Scarlet Eye.
Little Little Blanche; Little Bright Eye; Little Delicata; Little Linda; Little Pinkie.
Mediterranean
Mediterranean Apricot Broadeye, Mediterranean Cherry Red Halo, Mediterranean Dark Red, Mediterranean
Deep Rose; Mediterranean Deep Orchid; Mediterranean Halo Mix, Mediterranean Lilac; Mediterranean Mix,
Mediterranean Peach Improved, Mediterranean Peach XP, Mediterranean Pink, Mediterranean Polka Dot;
Mediterranean Red, Mediterranean Rose, Mediterranean Rose Red, Mediterranean Rose Hot, Mediterranean
White Broadeye; Mediterranean White, Mediterranean Strawberry.
Nirvana
Nirvana Cascade Lavender W/Eye, Nirvana Cascade Orchid, Nirvana Cascade Pink Splash, Nirvana Cascade
Rose, Nirvana Cascade Shell Pink, Nirvana Cascade White, Nirvana Pink Blush, Nirvana Red, Nirvana Dark
Red.
Pacifica
Pacifica Apricot, Pacifica Blush, Pacifica Burgundy, Pacifica Burgundy Halo, Pacifica Burgundy; Pacifica Cherry
Halo, Pacifica Cherry Red; Pacifica Coral; Pacifica Dark Red, Pacifica Deep Orchid; Pacifica Icy Pink; Pacifica
Lilac; Pacifica Lipstick Mix, Pacifica Magenta Halo, Pacifica Mix, Pacifica Orchid Halo; Pacifica Peach; Pacifica
Pink; Pacifica Polka Dot; Pacifica Punch; Pacifica Punch Halo, Pacifica Raspberry, Pacifica Really Red, Pacifica
Red, Pacifica Rose Halo, Pacifica Pure White.
Pretty Aureo-variegata, Bowles.
Solar
Solar Apple Blossom, Solar Apricot, Solar Blueberry, Solar Blush Pink, Solar Cherry with Eye, Solar Formula
Mixture, Solar Fresh Red, Solar Lilac, Solar Orange with Eye, Solar Orchid with Eye, Solar Pink, Solar
Raspberry with Eye, Solar Red, Solar Red with Eye, Solar White.
Stardust Stardust Orchid; Stardust Pink, Stardust Mix, Stardust Rose.
Sunstorm Sunstorm Apricot; Sunstorm Bright Red; Sunstorm Blush; Sunstorm Lilac; Sunstorm Orchid; Sunstorm Pink;Sunstorm Rose W/Eye; Sunstorm Violet W/Eye; SunstormWhite W/Eye.
Titan
Titan Apricot, Titan Blush, Titan Burgundy, Titan Cotton Candy Mix, Titan Dark Red, Titan Icy Pink, Titan
Lavender Blue Halo, Titan Lilac, Titan Mix, Titan Polka Dot, Titan Punch, Titan Pure White, Titan Rose, Titan
White.
Tropicana Tropicana Apricot, Tropicana Blush; Tropicana Bright Eye; Tropicana Pink; Tropicana Rose.
Tutti Frutti Agastache, Rose.
Victory
Victory Apricot, Victory Blue, Victory Bright Eye, Victory Carmine, Victory Carmine Rose, Victory Cranberry,
Victory Deep Apricot, Victory Deep Pink, Victory Grape, Victory Lavender, Victory Light Pink, Victory Pure
White, Victory Purple, Victory Red.
Viper Viper Apricot, Viper Grape, Viper Orchid Halo, Viper Pink, Viper Purple, Viper Purple Halo, Viper Red, ViperRed W/Eye, Viper Rose, Viper Watermelon.
Vitesse
Vitesse Apricot, Vitesse Blush, Vitesse Cranberry, Vitesse Fuchsia, Vitesse Grape, Vitesse Hot Pink, Vitesse
Lavender, Vitesse Orange, Vitesse Orchid, Vitesse Peach, Vitesse Peppermint, Vitesse Pink, Vitesse Purple,
Vitesse Raspberry, Vitesse Red W/Eye, Vitesse Rose, Vitesse Strawberry Red, Vitesse Strawberry Twist, Tropical
Orange, Vitesse White.
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was the first nonrutaceous plant found naturally infectedwith
Spiroplasma citri in the United States [76]. This pathogen
was subsequently discovered in Mediterranean countries,
including Morocco, Syria, Cyprus, and Turkey [77], and in
Southeast Asia, Malaysia [78]. Periwinkle is also known to be
susceptible to the cucumbermosaic virus (CMV), and disease
incidence has been reported in Australia [79], India [80], and
Malaysia [81].
Bedding plants such as periwinkle are susceptible tomany
damping-off diseases. MP is prone to blight, canker, leaf spot,
and root rot. Pathogenic fungi include Alternaria (leaf spot),
Rhizoctonia solani (stem, crown, and root rot), and Phy-
tophthora parasitica Dast. (foliars and stems). P. parasitica,
a soilborne fungus, causes serious losses and death in the
periwinkle with reports from India and theUnited States [82–
85]. Fusarium root rot has been reported from Taiwan [86].
Blight caused by P. nicotianae (syn. = P. parasitica) is one of
the most damaging diseases of MP in Florida [87]. Other
known blights include twig blight caused by Colletotrichum
dematium [88], foliar blight brought about by P. tropicalis
in Virginia [89], and gray mold blight affected by Botrytis
cinerea in the United States, Italy, and Taiwan [90–92]. Other
fungi identified to incite disease in periwinkle seedlings in
Taiwan include Botrytis cinerea, Colletotrichum gloeospori-
oides, Fusarium oxysporum, F. solani, P. parasitica, Pythium
aphanidermatum, Rhizoctonia solani, Sclerotinia sclerotio-
rum, and Sclerotium rolfsii [92]. Black root rot through
Thielaviopsis infection is the most serious root disease in
MP because it is very difficult to control [47]. Periwinkle
rust due to Puccinia vincae attack (http://donsgarden.co.uk/)
is another disease to be noted. Fungal problems can occur
under humid or wet conditions so care has to be exercised
to prevent overwatering. Insect pests are no major concern,
although aphids, thrips, spider mites, mealy bugs, and scale
insects can infest this plant [47].
6.2. Disease Management. Environmentally, a full-sun plant-
ing location reduced humidity levels, and increased air
circulation around the plants should be targeted. Potting
mixes have to be pathogen-free and new containers prepared
for each planting. Sanitation-wise, weeds should be kept
down, infected soils and plants removed immediately upon
detection, all equipment kept clean, and the planting area
cleared of old potting media and plant debris. In fertilization
and irrigation, avoid heavy fertilization and overwatering of
plants. Overhead irrigation and prolonged periods of leaf
wetness should be avoided with watering done only during
the day. Soil fertility has to be properly adjusted to pH
maintained at 5.5. Transplants need to be spaced at least
10–12 inches apart. Biocontrol of soilborne fungal pathogens
could be attempted with Trichoderma virens, binucleate
Rhizoctonia, or Burkholderia cepacia [47, 87, 93–96].
7. Phytochemistry
Two commercially and pharmacologically important cyto-
toxic dimeric alkaloids of MP, vinblastine and vincristine,
have been widely used for cancer chemotherapy, which are
only present in extremely low yields in the leaves [31].
The three-dimensional structure of these two compounds has
been featured in Figures 2(a)-2(b). In addition to alkaloids
and phenolics (as themost important compounds ofMP), the
presence of different chemical groups such as polyphenols,
alkaloids, steroids, flavonoid glycosides, anthocyanins, and
iridoid glucosides has been confirmed in different parts of
MP [97]. However, some evidence implicates the availability
of similar compounds in the leaves and stems of the plant,
but the same does not comply with the contents of seeds and
petals [98]. Flower extract of MP has been used as a natural
acid-base indicator [99, 100].
7.1. Major Alkaloids. All parts of the plant contain several
active alkaloids with an indole moiety. More than 130 indole
alkaloids, collectively termed terpenoid indole alkaloids
(TIAs), have been extracted from periwinkle [31, 101–104].
Some of these alkaloid compounds have distinct medicinal
properties. The alkaloid content is highest at the flowering
stage [50]. The principal alkaloids present in the aerial
(nonfloral) parts are VBL (vincaleukoblastine, VLB), VCR
(leurocristine, vincaleurocristine), vincarodine, vincoline,
leurocolombine, viramidine, vincathicine, vincubine, isosit-
sirikine, vincolidine, lochrovicine, catharanthine, vindoline,
leurosine, lochnerine, tetrahydroalstonine, and vindolinine.
Ajmalicine (raubasine), serpentine, and reserpine are the
main alkaloids in the root while coronaridine, 11-methoxy
tabersonine, tetrahydroalstonine, ajmalicine, vindorosidine,
and vincristine dominate in the flower. However of the over
hundred alkaloids discovered, only five consisting of vinblas-
tine, vincristine, 3󸀠,4󸀠-anhydrovinblastine, serpentine, and
ajmalicine are marketed [102]. Other Catharanthus species
such as C. longifolius, C. trichophyllus, and C. lanceus are
known to possess vindoline type alkaloids.
7.2. Major Phenolics. Phenolic compounds are a group of
metabolites available in all plant species. These compounds
can range from simple compounds bearing just one phenolic
hydroxyl to some more complex ones, like flavonoids, which
are often polyphenols. Besides alkaloids, MP produces a
wide spectrum of phenolic compounds with radical scav-
enging ability, including C6C1 compounds such as 2,3-
dihydroxybenzoic acid, as well as phenylpropanoids such as
cinnamic acid derivatives, flavonoids, and anthocyanins [97].
Mustafa and Verpoorte [97] have listed the most impor-
tant phenolic compounds of MP, including 2,3-DHBAG,
SA; SAG, benzoic acid, 2,5-DHBA, and 2,5-DHBAG, gallic
acid, glucovanillin, vanillic acid, glucovanillic acid, vanillyl
alcohol, vanillyl alcohol-phenyl-glucoside, C6C3/conjugated
C6C3: trans-cinnamic acid, hydroxytyrosol, ferulic acid,
chlorogenic acid, C6C3C6/conjugated C6C3C6: kaempferol,
trisaccharides, quercetin, syringetin glycosides, malvidin,
malvidin 3-O-glycosides, malvidin 3-O-(6-O-p-coumaroyl),
petunidin, petunidin 3-O-glucosides, and petunidin 3-O-(6-
O-p-coumaroyl).
8. Phytobioactivity
8.1. Ethnobotanical Importance. Decoctions of MP are men-
tioned in folklore remedies for treatment of diabetes, malaria
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Figure 2:The three-dimensional structures of themain anticancer compounds ofMP, (a) vincristine and (b) vinblastine, in a ball-stickmodel
(http://www.chemspider.com/ImageView).
[105], dengue fever, dysentery [106], insect bites [107], skin
infection, diarrhea, leukemia, eye irritation, dyspepsia,
dysentery, toothache, sore throat, and lung congestion [106].
The root of the plant is reported to be a tonic and possess
hypotensive, sedative, and tranquillizing properties [108].
In Ayurveda, it is used for treating diabetes. Hypoglycemic
activity of aqueous extracts from MP has been proved in
modern studies, as well [109]. In Madagascar, the bitter and
astringent leaves have been applied as an emetic; roots have
been used as a purgative, vermifuge, depurative, hemostatic
agent and toothache remedy. In the Philippines, the leaf
decoction is an herbal treatment for diabetes, young leaves
are for stomach cramps, and root decoction is for intestinal
parasitism. Mauritians employ infusion of leaves for indiges-
tion and dyspepsia. In India (Orissa and Assam), juices from
the leaves are used to treat wasp stings while roots and leaves
are utilized as anticarcinogenic agents [18, 110].
MP floral extracts enjoy wide usage in many countries
as a remedy for many ailments: Cuba and Jamaica: eyewash
for infants; Bahamas: asthma; Bermuda: high blood pres-
sure; Indo-China: dysmenorrhea; Surinam and throughout
the Caribbean: eye irritation/infections, malaria, menstrual
pains, and diaphoresis. Ugandans put faith in leaf infusions to
treat stomach ulcers while Batswana ground leaves inmilk for
mature abscesses. In Togo, a root decoction is taken to treat
dysmenorrhoea [18, 110]. Even in developed countries such as
Europe,MP is used as a folk remedy for diabetes for centuries.
InHawaii, the plant is boiled tomake a poultice stop bleeding.
The Chinese have widely applied this versatile herb in the
treatment of leukemia, hypertension, lymphosarcoma, and
giant follicular lymphoma while adapting it as an astringent,
diuretic, and cough remedy. Similarly, in central and south
America, it is popular as a homemade cold remedy to
ease lung congestion, inflammation, and sore throat while
it is trusted as an alternative medical treatment source for
leukemia inHongKong andKorea. Japan has targetedMP for
arresting diabetes and malignant lymphatic tumours [111]. In
addition, modern research has revealed a broad spectrum of
medicinal applications for the herb (Table 5).
8.2. Toxicity and Side Effects. MP can be dangerous if con-
sumed orally. It can be hallucinogenic and is cited as such
(under its synonym Vinca rosea) in the Louisiana State
Act 159. TIAs have been applied clinically since the end of
the 1950s as major drugs in the treatment of acute lym-
phoblastic leukemia, non-Hodgkin lymphomas, myeloma,
andHodgkin lymphoma [112].Despite their benefits, all of the
MP alkaloids have neurotoxic activity, especially vincristine,
affecting neurotransmission [113]. Vincristine and vinblastine
are highly toxic antimitotics, blocking mitosis in metaphase
after binding to the microtubules [114]. Moreover, many side
effects have been reported for these drugs comprising myelo-
suppression, alopecia, abdominal cramps, constipation, nau-
sea/vomiting, paralytic ileus, ulcerations of the mouth, hep-
atocellular damage, kidney impairment, pulmonary fibrosis,
urinary retention, amenorrhoea, azoospermia, orthostatic
hypotension, and hypertension [113, 115, 116]. The dosage and
administration must be carefully controlled to reduce side
effects [112].
8.3. Formulations and International Trade. The two key phar-
maceutical dimeric alkaloid compounds, VBL andVCR, exist
mainly in the aerial parts of the plant in extremely low
concentrations, the latter quantitatively much less than the
former [50, 117–119]. Vincristine sulfate, originally known
as leurocristine, is the only effective antileukemic drug that
reduces white blood cell count drastically; since the 1950s, it
has increased the survival rate of childrenwith leukemia from
20% to 80%. It is one of the most expensive plant products on
the market with considerable side effects. Vinblastine simi-
larly decreases the quantity of white blood cells in the blood
[112]. Vinblastine sulfate has now been marketed for more
than 40 years as an anticancer drug. It has proven effective
against Hodgkin’s disease. Vincristine sulfate and vinblastine
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Table 5: List of the most important studies on the medicinal effects of Catharanthus roseus.
Application
Modern researches References
In vitro In vivo
Acetylcholinesterase and cholinergic
antagonism inhibition Microplate assay
Male Wistar rats∗ [166, 167]
Alzheimer’s syndrome Human (clinical trial) [168]
Anthelminthic activity Pheretima posthuma [169]
Antiandrogenic activity Mice [170]
Antiangiogenesis activity Chicken eggs [171]
Antibacterial (antiseptic) activity Bacteria [106, 172–175]
Antidysenteric activity Wistar rats [176]
Antifertility effect Male rat [115, 177, 178]
Antifungal activity Trichophyton rubrumHendersonula toruloidea
[179, 180]
Antihyperglycemic activity (antidiabetic) Mice, rat, rabbit Wistar albino rats [109, 181–188]
Antihypercholesterolemic activity
(antihyperlipidemic) Rabbit, rat
[184, 189]
Anti-inflammatory activity Rat [189]
Antimutagenic activity Micronucleated erythrocytes [190]
Antineoplastic activity Mice, rat Clinical use [113, 191–198]
Antioxidant activity Rat [61, 184, 199]
Antiplasmodial activity Human erythrocytes [200, 201]
Antiproliferative activity Human cells [202, 203]
Antispermatogenic Male rat, mice [204, 205]
Blood cleanser [206]
Cytochrome P450 inhibition CYP2D6 [207]
Cytotoxic activity Human cell line [208, 209]
Enhances kidney and liver functions Wistar rat [185, 210]
Epididymal dysfunction Rat [211]
Generate giant spermatogonial cells Albino rat [212]
Hypotensive activity Rat [108]
Larvicidal activity Anopheles stephensi (malariavector); Aedes aegypti
[213, 214]
Regression of accessory reproductive
organs Male Wistar rats
[215]
Regression of entire reproductive system Male rat [216]
Stomachic — [108, 217]
Tonic — [108, 217]
Tranquilizing and sedative action — [101, 108, 217]
Wound healing Rat [218]
∗The research was done ex vivo.
sulfate are being sold for a total US$ 100 million per year
[50, 120]. Developing food stuff incorporated by fresh leaves
ofMP gives rise to the economic importance of the herbwhile
such products possess both pharmaceutical and nutritional
properties, simultaneously [121].
These injectable drugs and their semisynthetic analogues
such as vinorelbine (VRLB) and vindesine (VDS) interfere
with the division of cancer cells [31, 122–126]. Navelbine
(5󸀠-noranhydrovinblastine) is a semisynthetic vinca alkaloid
with complete microtubule depolymerization ability, broader
antitumor activity, and a lower neurotoxicity than VBL and
VCR because it selectively interferes with tubulin assembly
[127]. Fully synthetic vincristine is far less efficient (only
20% efficiency) compared to the natural product derived
from MP, and hence the importance of the species and its
bioactive compounds is unchallenged owing to their complex
structures [119]. The other valuable therapeutic alkaloid
“ajmalicine” is a constituent of hypotensive drugs employed
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in the treatment of high blood pressure. Two to three hundred
tons of MP roots is required for 3600Kg annual world
production of ajmalicine [119].
9. Promising Horizons in Biosynthesis of
the Phytochemicals
9.1. TIAs Pathways Studies. There are two different metabolic
pathways for the biosynthesis of terpenoids leading to the for-
mation of the C
5
central precursor isopentenyl diphosphate
(IPP), namely, the classical cytosolic mevalonate pathway
and the mevalonate-independent plastidic 2-C-methyl-D-
erythritol 4-phosphate (MEP) pathway. The biosynthesis
of MP TIAs starts with the condensation of tryptamine
(shikimate pathway) and secologanin (MEPpathway) to form
the key intermediate strictosidine, the common backbone
structure of all TIAs [128]. However, the alkaloid pathway in
MP and the involved genes remain partly unknown [128], but
gene-to-metabolite networks studies for understanding the
biosynthesis of TIAs in MP using the cDNA-amplified frag-
ment length polymorphism (AFLP) markers have revealed
valuable information [129]. At the same time, the drawn
networks increase the practical potential of metabolic engi-
neering of MP.
9.2. Cell and Tissue Culture. VBL andVCR are only produced
in very low concentrations in MP.The high therapeutic value
and cost of production of the minute amounts of these bis-
indole alkaloids (VBL and VCR) have prompted extensive
efforts to increase their levels by cell-tissue culture and
mutation induction [130–132]. In vitro methods such as cell
suspension, hairy root and callus cultures, shoot cultures,
metabolic engineering, and regulation studies to improve
the phytochemicals production are uncontested shortcut
strategies to those time-consuming conventional breeding
methods. In other words, when there is a high demand for
plant-based pharmaceutics and only low amounts accumu-
late in plants, plant cell cultures have shown to be an efficient
alternative production system of valuable phytochemicals on
a large scale. Rapid reproduction and preservation of natural
sources are of the beneficial points of such an approach
[133]. Plant growth regulators (PGRs) activate plant natural
defence mechanisms, thereby leading to increase the biosyn-
thesis of the secondary metabolites in plants. In this regard,
application of PGRs like methyl jasmonate (MeJA), dimethyl
sulfoxide (DMSO), jasmonates, and salicylic acid as elicitors
of secondary metabolites has led to positive results, in recent
experiments [128, 134, 135]. Isolation of VBL and VCR using
callus culture [136], cell culture [137], shoot culture [138],
semisynthetic [139] and totally synthetic approaches [140] is
currently considered. Unfortunately, drug supplementation
using the aforementioned techniques is limited and cannot
meet the existing requirements. Application of artemisinic
acid as a useful elicitor has recently been highlighted in
suspension-cultured cells of MP [141].
9.3. Plant-Fungal Symbiotic Fashion. As mentioned, despite
a nonstop explorative trend, the desired level of production
of the bioactive compounds such as VBL and VCR has still
not been achieved at optimum level [142]. For this reason,
isolation of endophytic fungi from the MP plant has been
taken into consideration as an alternative solution, more
recently [143]. Investigations on the pathobiology of the
species have led to very exciting results. Mechanistically,
endophytic fungi reside in a symbiotic fashion inside peri-
winkle plant, imitate their chemistry, and produce the same
natural products as their hosts and are thus being screened for
the production of themost valuable anticancer compounds of
the herb, namely, VBL and VCR. In line with this, researchers
took the first steps toward producing VCR using Fusarium
oxysporum, an endophyte of MP [144, 145]. Later on, Guo
and Kunming [146] obtained VBL by Alternaria species
isolated from the same plant found in China and showed
the production based upon thin layer chromatography (TLC)
and high performance liquid chromatography (HPLC) only.
Eventually, the latest innovation in this area happened by
employing the same endophytic fungus (F. oxysporum; strain
AA-CRL-6), for isolation of both anticancer compoundsVBL
and VCR in appreciable amounts, successfully [147].
9.4. Functional Genomics and Proteomics Exploration. The
biosynthesis of VBL includesmore than 20 enzymatic phases,
in which nine out of 20 are now well characterized at the
enzyme and gene level, and several regulatory genes of the
pathway (ORCAs) have also been cloned [148]. Proteomic
analysis of the plant using two-dimensional electrophoresis
led to the identification of 58 proteins, including two iso-
forms of strictosidine synthase (EC 4.3.3.2), which catalyze
the formation of strictosidine in the alkaloid biosynthesis;
tryptophan synthase (EC 4.1.1.28), which is required as a
supplying source of the alkaloid precursor tryptamine; 12-
oxophytodienoate reductase, which is indirectly involved
in the alkaloid biosynthesis as it catalyzes the last step
in the biosynthesis of the regulator jasmonic acid [149].
Recently, scientists have detected a higher number of proteins
using two-dimensional differential in gel electrophoresis
(2D-DIGE) technique in two different lines of the herb,
358 proteins in one and 1663 in another line, most of
which corresponded to housekeeping proteins or involved in
primary metabolism [150]. Of these, a total of 63 enzymes
only potentially involved in secondary metabolism, of which
22 were related to TIAs biosynthesis and 16 were predicted
transporters putatively involved in secondary metabolite
transport. As amatter of fact, these results are important steps
towards elucidating the proteome of MP, which are essential
to understanding the modality of TIAs biosynthesis [150].
9.4.1. Transformation of Specific Genes. Quantitative analysis
of metabolic pathways in MP revealed that metabolically
engineered hairy roots can lead to overproduction of TIAs
[151]. Recent studies are focused on cloning, characterization,
and transformation of the genes involved with the related
biosynthetic cycles such as CrPrx1 that belongs to an evolu-
tionary branch of vacuolar class III peroxidases [148].
9.4.2. Transformation of Genes Affecting the Intermediate
Compounds. Recent genetic engineering of MP not only is
limited to the genes enhancing the VBL and VCR production
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directly, but also includes the genes augmenting the biosyn-
thesis of the intermediate compounds such as vindoline, an
important intermediate leading to VBL and VCR. Genes
such as desacetoxyvindoline-4-hydroxylase-like (d4h-like),
ORCA3 (octadecanoid-derivative responsive Catharanthus
AP2-domain), and G10H (geraniol 10-hydroxylase) are suit-
able examples of the aforementioned trend [152, 153].
9.4.3. Application of Reverse Genetics for Gene Identification.
The concept of “reverse genetics” is widely used for charac-
terization of plant enzymes (more precisely genes encoding
enzymes involved in alkaloid metabolism) in which the
partial sequencing of proteins is carried out after purification
of the isolated enzymes from plants or plant cell culture by
traditional biochemical chromatography techniques. These
sequences are consequently used to identify the correspond-
ing gene from a plant cDNA library [154]. Homology-based
cloning of candidate genes and their succeeding functional
testing in heterologous expression systems are hastening the
pace at which the gene catalogues of alkaloid biosynthesis
are developing. For example, putrescineN-methyltransferase,
the first enzyme in the nicotine-specific pathway, and an
isoflavone reductase-like enzyme putatively involved in nico-
tine biosynthesis are both expressed specifically in the cortex
and endodermis of tobacco root tips. However, intense
expression of these enzymes shifts to the xylem parenchyma
and outer cortex cells in more differentiated parts of the
root [155]. This developmentally regulated spatial expression
pattern may be complicatedly associated with nicotine dis-
semination in tobacco tissues and organs. Tropane alkaloids,
as well as nicotine, are mainly synthesized in the root and
transported to aerial parts where they accumulate in vacuoles
at high levels. Analysis of xylem saps taken from the stem
shows that these alkaloids are transported via the xylem [156].
9.4.4. Promoter Engineering. The gene transformation pro-
cedure not only is limited to transferring the genes with
the “constitutive” promoters, but also can be implemented
by fusing the “regulated” promoters to the target gene. The
best example of the mentioned process is the agrobacterium-
mediated transformation of the hydroxymethylbutenyl 4-
diphosphate synthase gene (HDS) from the methyl erythritol
phosphate (MEP) pathway by replacing an HDS-GUS fused
promoter with the constitutive CaMV35S promoter. The
functional characterization of the transformed cells con-
firmed the induction of HDS promoter by several hormonal
indicators (auxin, cytokinin,methyl jasmonate, and ethylene)
leading to the MIAs production in MP [157].
9.4.5. Gene Silencing. Conceivably, one of the most advanced
technologies to scrutinize the MIAs metabolism in MP is
the virus-induced gene silencing (VIGS) strategy by estab-
lishing tobacco rattle virus- (TRV-) based approach [158].
Secologanin is a versatile iridoid and a precursor for the
assembly of countless MIAs as well as a number of quinoline
alkaloids. In a very recent attempt, employing the VIGS-
based method led to the identification of the 7-deoxyloganic
acid 7-hydroxylase (CrDL7H) gene involved in the third to
the last step of secologanin biosynthesis [121]. Silencing the
mentioned gene reduced the level of secologanin up to at least
70% and increased the level of 7-deoxyloganic acid to over
4mg g−1 fresh leaf weight compared with the control plants
in which this iridoid is not detected. Functional expression
of this gene confirmed its priority as a specific substrate for
7-deoxyloganic acid compared to other related substrates.
Therefore, it seems that hydroxylation precedes carboxy-O-
methylation in the secologanin pathway leading to the MIAs
biosynthesis in C. roseus [121].
10. Conclusion
Nowadays, the demand for natural products and plant-
based medicines is growing throughout the world. MP is a
remarkable herb owing to its broad spectrum of applications.
Apart from its natural supply of anticancer compounds for
medicine on the international market, it ranks highly as a
popular ornamental plant in the horticultural industry and
as a model plant for studies in phytopathology as well as
biotechnology. The ultimate goal of current research is to
produceMP disease-resistant cultivars with a high content of
antitumor alkaloids. Several cultivars have been introduced
primarily as ornamental plants with their alkaloid com-
position, agronomic performance, and genetic affiliations
unknown. As such, agronomic and genetic elucidation of new
cultivars with exploration of their physiology and secondary
metabolism are required for achieving a high quantity and
quality output of TIAs. It is unfortunate that MP anticancer
drugs have several adverse side effects. This renders further
exploration of the clinical pharmacokinetics of MP alkaloids
and drug-drug interactions indispensable.
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